“ My approach to client relations is simple: add value at every interaction.
Venantius (Ven) is one of the most recognized lawyers for Hong Kong capital markets deals due to his involvement in many of the early overseas B-Share and H-Share offerings by major PRC state-owned enterprises. He has more than 25 years of experience in a broad range of corporate and securities matters, including Hong Kong IPOs, dual listings, secondary offerings, corporate restructuring, and private and public M&A transactions.
He has been practicing corporate law in Hong Kong since 1993 and was involved in the Hong Kong IPOs of various leading Chinese state-owned and private enterprises including Angang Steel, Jilin Chemical, Beijing Yanhua Petrochemical, China CNR Corporation, China Gold International Resources Corp., Shanghai Fosun Pharmaceutical Group, Shanghai Dazhong Public Utilities, Sinopharm Group, Dalian Port, China Zhongwang, Kingsoft Corporation, and China Huiyuan Juice.
In addition to his capital markets expertise, Ven has been involved in a number of substantial merger and acquisition deals in China, including:
From 2005 to 2018 Ven headed our Hong Kong office and from 2011 to 2013 he served on our board of directors. He is fluent in English and Mandarin. He is registered as a Senior Consultant with the Law Society of Hong Kong.
Shanghai Dazhong Public Utilities (Group) Co., Ltd. in relation to its HK$1.7 billion offering of H shares on the Hong Kong Stock Exchange. Shanghai Dazhong is an A-share listed company on the Shanghai Stock Exchange and is a leading public utility service provider in Shanghai.
Sole sponsor BOCI Asia Limited in relation to Jacobson Pharma Corporation Limited’s HK$650 million IPO on the Hong Kong Stock Exchange. Jacobson Pharma Corporation Limited is the largest generic drug company in Hong Kong and owns household brands such as Po Chai Pills (Puji Pills).
Sole sponsor BOCOM International (Asia) Limited and joint lead managers DBS Asia Capital Limited in relation to PuraPharm Corporation Limited’s HK$430 million IPO on the Hong Kong Stock Exchange. PuraPharm Corporation Limited is a leading Hong Kong-based Chinese medicine company. It is the largest supplier of concentrated Chinese medicine granule products in Hong Kong.
CITIC Securities as sole sponsor and CLSA as sole global coordinator, sole bookrunner and sole lead manager in Dynagreen Environmental Protection Group Co Ltd’ s HK$1.11 billion H-share IPO on the Hong Kong Stock Exchange. Dynagreen is a leading waste-to-energy company in PRC focusing on municipal solid waste treatment.
China CNR Corporation Limited in relation to its US$1.2 billion H-share IPO on the Hong Kong Stock Exchange. China CNR Corporation Limited is the world’s largest rolling stock manufacturer.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in its US$512 million initial public offering on the Hong Kong Stock Exchange, which was the third largest Hong Kong IPO of 2012 at the time of listing.
Dalian Port (PDA) Company Limited, China’s largest oil and container port, in Hong Kong listing and compliance issues with respect to its US$857 million A-share initial public offering on the Shanghai Stock Exchange. The firm also represented Dalian Port in its US$320 million initial public offering on the Hong Kong Stock Exchange, which included a Rule 144A/Regulation S global offering.
J.P. Morgan and CCB International as joint bookrunners in the US$470 million initial public offering of China Zhengtong Auto Services Holdings Limited on the Hong Kong Stock Exchange. China Zhengtong is the second largest BMW dealer and a major 4S dealership group in China.
China Gold International Resources Corp. in its US$309 million initial public offering in Hong Kong. Citi and BOCI Asia acted as joint bookrunners and joint lead managers. China Gold is controlled by China’s biggest gold company.
CICC, UBS, Morgan Stanley, Citi, and Deutsche Bank as underwriters in the US$1.1 billion initial public offering of Sinopharm Group Company Limited on the Hong Kong Stock Exchange. Sinopharm is the largest distributor of pharmaceutical and healthcare products in China. This listing is one of the largest IPOs in 2009, and won a number of industry accolades including Asia Equity Deal of the Year at the IFR Asia Awards 2009 and Best IPO Deal of the Year at the FinanceAsia Awards 2009.
UBS, J.P. Morgan, Macquarie, and CITIC Securities as joint lead managers in the US$1.2 billion initial public offering of China Zhongwang Holdings Limited on the Hong Kong Stock Exchange with a Rule 144A offering in the United States. China Zhongwang Holdings is Asia’s largest maker of aluminum extrusion products by capacity. This listing is one of the largest IPOs in 2009.
Kingsoft Corporation Limited, a major China-based software developer and online gaming company, as Hong Kong and U.S. counsel in its US$115 million initial public offering on the Hong Kong Stock Exchange. Deutsche Bank and Lehman Brothers were joint underwriters.
China Huiyuan Juice Group Ltd. in its US$345 million initial public offering under Rule 144A/Regulation S and listing on the Hong Kong Stock Exchange, and its earlier issuance of convertible bonds amounting to an approximate total of US$222.25 million. China Huiyuan Juice Group Ltd. is the leading fruit and vegetable juice manufacturer in China, holding 42% of the market share for pure-fruit juice beverages.
O2 Micro Inc. in connection with its primary listing by introduction on the Hong Kong Stock Exchange, the first company to have a dual primary listing on the Nasdaq National Market and the Main Board of the Hong Kong Stock Exchange.
Haitong International Securities as placing agent in connection with Northeast Electric Development Co. Ltd.’s issue of new shares to HNA Group for HK$374 million.
China Resources Power Company Limited, one of the largest Hong Kong-listed power generation companies in Mainland China, in its top-up share placement that raised approximately US$626.4 million. Morgan Stanley and Citi were joint placing agents in this share placement.
BOCI, HSBC, UBS and BNP Paribas as joint lead managers and underwriters on the RMB600 million Regulation S international offering of three-year senior notes by Golden Wheel Tiandi Holdings Limited, a PRC property developer listed in Hong Kong.
Angang Steel Company Limited in its unprecedented dual A- and H-share rights issue. A total of 195.8 million H-shares and 1.11 billion A-shares were issued, raising approximately US$2.6 billion. Angang Steel Company is listed on the Hong Kong Stock Exchange and the Shenzhen Stock Exchange, and is China’s second largest steel producer by production.
Mandra Forestry Holdings Limited in its US$195 million issue of guaranteed senior notes and warrants.
Hong Kong Stock Exchange-listed NetDragon Websoft Holdings Limited in its US$137.5 million acquisition of Edmodo, Inc., one of the largest education technology platforms in the world.
Nan Hai Corporation Limited (stock code: 680) in its RMB3.39 billion (approximately $480 million) acquisition of the whole cinema operation business in the PRC from Orange Sky Golden Harvest Entertainment (Holdings) Limited (stock code: 1132) and the other minority shareholder through its wholly-owned subsidiary.
Angang New Steel Company Limited in its US$2.2 billion corporate restructuring and buy-out of operating assets from its controlling shareholder, Anshan Iron & Steel Group Company.
Jilin Chemical Industrial Company Limited in the US$470 million takeover offer made by PetroChina Company Limited, the controlling shareholder of Jilin Chemical, to purchase all of the outstanding H shares, American Depository Shares and A shares of Jilin Chemical and the subsequent withdrawal of its listings from the Hong Kong Stock Exchange, New York Stock Exchange and Shenzhen Stock Exchange. This transaction was the first-ever voluntary takeover offer for a company with listed domestic and foreign shares. China Resources Power’s US$669 million acquisition of stake in Daning coal mine
China Resources Power Holdings Company Limited in its US$669 million acquisition of a 56% stake in Daning coal mine in Shanxi Province, northern China, from Banpu Public Company Limited, a major Thailand-based natural resources company. The acquisition is part of CR Power’s efforts to secure and expand its coal supply base for its power generation business.
Legal 500 Asia Pacific 2019-2021
Chambers Asia Pacific 2019-2020
IFLR 1000 2019